Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is a randomized, placebo controlled, multi-center, single dose study to evaluate
cardiac hemodynamics and safety of iv SLV320 in 110 subjects with congestive heart failure
requiring diuretic treatment. Each subject will receive one dose of SLV320 or placebo or
furosemide. The study consists of three visits (or study days when in-subjects are included).
Ambulatory subjects will be in hospital for two nights and one day.